Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, and CHEMO, a multinational and pharmaceutical company with strong industrial capacities for APIs and Finished-Dosage-Forms (FDF), have formed a partnership to offer complete contract product development and commercial manufacturing of hormone-eluting devices. Particle Sciences is a world leader in the formulation, testing and scale up drug/device combinations and has been working with CHEMO for several years on a number of hormone-based polymeric combination products. According to Mark Mitchnick, CEO of ... read more

The largest genetics study to date of type 2 diabetes (T2D) has identified new gene variants associated with risk for the common metabolic disease. An international scientific consortium, studying multiethnic populations, uncovered genes that may point to biological targets for developing more effective drugs for T2D. Multiple genes and environmental factors interact with T2D, which affects nearly 300 million people worldwide. The majority of the gene variants remain undiscovered. "Scientists have identified only about 10 percent of the genetic variants contributing to ... read more

QlikTech, (NASDAQ: QLIK) a leader in Business Discovery – user-driven Business Intelligence, today announced it has been positioned by Gartner, Inc. in the Leaders Quadrant in the 2012 Business Intelligence Platform Magic Quadrant report*. QlikTech secured its coveted position in ... read more

Monroe Online Endeavors LLC today introduced a new Web site, www.Light-My-Life.com, selling a wide array of new and competitively priced home lighting products. Lighting found on Light-My-Life.com includes accent lighting, ceiling medallions, chandeliers, floor lights, table lights, wall lights and more. The company will continue to add products as it grows and adds additional product categories to its new Web site, including outdoor lighting. President of Monroe Online Endeavors, Janice Monroe, said, "A new chandelier or even accent lighting can ... read more

Gene therapy for congenital blindness has taken another step forward, as researchers further improved vision in three adult patients previously treated in one eye. After receiving the same treatment in their other eye, the patients became better able to see in dim light, and two were able to navigate obstacles in low-light situations. No adverse effects occurred. Neither the first treatment nor the readministered treatment triggered an immune reaction that cancelled the benefits of the inserted genes, as has occurred in ... read more

PBMs Will Save Pennsylvania Consumers and Payers $89 Billion Over the Next Decade ... read more

Comcast Corporation, (NASDAQ: CMCSA, CMCSK), one of the world’s leading media, entertainment and communications companies, announced today that Beth Arnholt has joined the company in a new role as Vice President of Integrated Talent Management. In this newly created position, Ms. Arnholt will partner across Comcast ... read more

Mylan Inc. (Nasdaq: MYL) CEO Heather Bresch today testified before the U.S. House of Representatives Energy and Commerce Committee at a hearing hosted by the subcommittee on Health entitled "Review of the Proposed Generic Drug and Biosimilars User Fees and Further Examination of Drug Shortages." In her testimony, Bresch commented: "Every consumer should have the peace of mind in knowing that every prescription, brand or generic, dispensed in the United States, is held to the same standard of quality regardless of ... read more

InterDigital, Inc. (NASDAQ: IDCC) today announced a collaboration with Ittiam Systems Private Limited. Together, the companies have developed a system to extend Wi-Fi® technology into TV White Space (TVWS) and other under-utilized frequency bands. Integrated Dynamic Spectrum Management technology harvests TVWS and other available frequency ... read more

On February 20, 2012, the Victor Center for the Prevention of Jewish Genetic Diseases at Einstein Medical Center in Philadelphia will conduct a community-wide screening for potential carriers of 19 Jewish genetic diseases from 10:00 AM - 3:00 PM at MossRehab at the Marketplace Design Center, located at 2400 Market Street in Philadelphia. The maximum out-of-pocket cost for insured individuals screened is $25, a significant fee reduction from prior screenings. Individuals must be pre-registered at www.victorcenters.org/screening and those ... read more

The Board of Directors of AMETEK, Inc. (NYSE:AME) declared a regular quarterly dividend of six cents per share for the first quarter ending March 31, 2012. The first quarter dividend is payable March 30, 2012, to shareholders of record as of March 16, 2012. Contact: Kevin Coleman (610) 889-5247 SOURCE AMETEK, Inc. ... read more

Unisys Corporation (NYSE: UIS) today announced that its UK subsidiary has completed an innovative data center transformation project for The Isle of Man Government. The government's modernized IT environment has delivered multiple cost savings to date and reduced provisioning times for new network and service availability -- from 90 days to less than one. The solution was designed and delivered on budget by Unisys to underpin the Isle of Man's public service initiative to transform public services and provide 24/365 access ... read more

Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Doxycycline Hyclate Delayed-release (DR) Tablets USP, 150 mg. This product is the generic version of Mayne Pharma's Doryx® (marketed by Warner Chilcott), which is a tetracycline-class antimicrobial. Mylan CEO Heather Bresch commented: "We are gratified by FDA's approval of our generic Doryx 150 mg product. We have ... read more

SunGard, one of the world’s leading software and technology services companies, today reported results for the fourth quarter and full-year ended December 31, 2011. For the fourth quarter, revenue was $1.17 billion, down 3% year over year. Excluding one of our global trading businesses, a broker/dealer, ... read more

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter 2011 on Thursday, February 23, 2012 before the opening of the U.S. financial markets. The Company will also conduct a conference call that day at 10:00 a.m. ET to discuss results and highlights of the fourth quarter 2011. The presentation slides to be used during the call will be available on the "For Investors" section of the Company's web site under the "Presentations" ... read more

BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced its financial results for the fourth quarter and year ended December 31, 2011. Financial highlights for the quarter ended December 31, 2011 include: ... read more

Almac is pleased to announce the doubling of analytical capacity at its 240,000 sq. ft. North American Headquarters. The facility - built on a 40 acre site in Souderton, north of Philadelphia (PA) - and occupied since 2010, delivers full-service, integrated clinical packaging, drug ... read more

Press Kit Materials are Available at: http://www.tradeshownews.com/events/HIMSS12/CenTrak/   ... read more

USA Technologies, Inc. (NASDAQ: USAT), a leader of wireless, cashless payment and M2M telemetry solutions for self-serve, small-ticket retail industries, today reported results for the second quarter of fiscal 2012 (ended December 31, 2011). Second Quarter Highlights ... read more

Synergis Technologies, Inc. today announced their designation as an Autodesk Platinum Tier Value-Added Reseller (VAR), with Manufacturing; Architecture, Engineering, and Construction; and Education authorization. Platinum Tier partners comprise the highest level of the Autodesk Value Added Reseller program, which incorporates Autodesk software solutions along with proven and measurable technical expertise in a specific industry or unique business. Platinum partners provide their customers with best-in-class full solutions from pre- and post-sales support, consulting, training, implementation, and customization. Synergis works ... read more